Personal Genome Diagnostics Raises $75 Million to Bring Regulated IVD Genomic Tests to Cancer Patients Worldwide

Series B Financing Co-led by Bristol-Myers Squibb and New Enterprise Associates BALTIMORE, Jan. 4, 2018 -- (Healthcare Sales & Marketing Network) -- Personal Genome Diagnostics Inc. (PGDx) today announced a $75 million Series B financing co-led by new ... Diagnostics, Oncology, Venture Capital Personal Genome Diagnostics
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news